89 related articles for article (PubMed ID: 9368625)
1. Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production.
Serra VA; Cretin F; Pépin E; Gabert FM; Marche PN
Eur J Immunol; 1997 Oct; 27(10):2673-9. PubMed ID: 9368625
[TBL] [Abstract][Full Text] [Related]
2. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
3. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
Arvieux J; Yssel H; Colomb MG
Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
[TBL] [Abstract][Full Text] [Related]
4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
5. C3b covalently associated to tetanus toxin modulates TT processing and presentation by U937 cells.
Rey-Millet CA; Villiers CL; Gabert FM; Chesne S; Colomb MG
Mol Immunol; 1994 Dec; 31(17):1321-7. PubMed ID: 7997244
[TBL] [Abstract][Full Text] [Related]
6. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
7. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
8. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
Théry C; Brachet V; Regnault A; Rescigno M; Ricciardi-Castagnoli P; Bonnerot C; Amigorena S
J Immunol; 1998 Sep; 161(5):2106-13. PubMed ID: 9725201
[TBL] [Abstract][Full Text] [Related]
9. Disulfide linkage between C3b and tetanus toxin on tetanus toxin-specific EBV-transformed B cells.
Jacquier MR; Gabert FM; Villiers CL; Colomb MG
J Immunol; 1993 May; 150(10):4253-60. PubMed ID: 8387092
[TBL] [Abstract][Full Text] [Related]
10. C3b complexation diversifies naturally processed T cell epitopes.
Cretin FC; Serra VA; Villiers MB; Laharie AM; Marche PN; Gabert FM
Mol Immunol; 2007 Apr; 44(11):2893-9. PubMed ID: 17320958
[TBL] [Abstract][Full Text] [Related]
11. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
13. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
14. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
15. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
16. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
17. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.
Nijenhuis M; Calafat J; Kuijpers KC; Janssen H; de Haas M; Nordeng TW; Bakke O; Neefjes JJ
Eur J Immunol; 1994 Apr; 24(4):873-83. PubMed ID: 8149958
[TBL] [Abstract][Full Text] [Related]
18. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
Albert LJ; Ghumman B; Watts TH
J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
[TBL] [Abstract][Full Text] [Related]
19. Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells.
Villiers MB; Villiers CL; Jacquier-Sarlin MR; Gabert FM; Journet AM; Colomb MG
Immunology; 1996 Nov; 89(3):348-55. PubMed ID: 8958046
[TBL] [Abstract][Full Text] [Related]
20. Abnormal association between invariant chain and HLA class II alpha and beta chains in chronic lymphocytic leukemia.
Veenstra H; Jacobs P; Dowdle EB
Cell Immunol; 1996 Jul; 171(1):68-73. PubMed ID: 8660839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
